about
Sequencing pools of individuals — mining genome-wide polymorphism data without big fundingCancer genome landscapesKIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancerSomatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2Intratumor heterogeneity: evolution through space and timeMutational processes molding the genomes of 21 breast cancersThe haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell lineClonal origin and spread of metastatic prostate cancerEvaluation and consequences of heterogeneity in the circulating tumor cell compartmentCancer Evolution and the Limits of Predictability in Precision Cancer MedicineComputational Cancer Biology: An Evolutionary PerspectiveDifferent Facets of Copy Number Changes: Permanent, Transient, and AdaptiveGenome management and mismanagement--cell-level opportunities and challenges of whole-genome duplicationIntra-tumor heterogeneity of cancer cells and its implications for cancer treatmentTranslational implications of tumor heterogeneityHigh-throughput sequencing for biology and medicineDeciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicineAcute myeloid leukaemia: a paradigm for the clonal evolution of cancer?The niche under siege: novel targets for metastasis therapyEvolution and dynamics of pancreatic cancer progressionMutational signatures: the patterns of somatic mutations hidden in cancer genomesGenomic sequencing in cancerNext-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situBioinformatics for cancer immunology and immunotherapyTumour heterogeneity and the evolution of polyclonal drug resistanceCancer evolution: mathematical models and computational inferenceGenomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancersGenomic profiling of breast cancersEmerging patterns of somatic mutations in cancerEvolution of the cancer genomeAnti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefitsConcepts in solid tumor evolutionPatient-derived xenograft models of breast cancer and their predictive powerClonal evolution in hematological malignancies and therapeutic implicationsSciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolutionActivation-induced deoxycytidine deaminase (AID) co-transcriptional scanning at single-molecule resolution.Turning hepatic cancer stem cells inside out--a deeper understanding through multiple perspectives.SF3B1 mutations in chronic lymphocytic leukemia.Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkersToward precision medicine of breast cancer
P2860
Q22121997-80AD0685-684F-4B43-AE86-75DDCB8D4D6FQ22242276-54EDFA20-7F39-476A-8CBB-70166EBEE476Q24296484-D4C6F391-75F3-4F26-837C-316A930190CFQ24568313-1C4A2E60-ADAC-48C1-8FCB-0DFDD2602F80Q24598678-BE787C9B-2586-4CB3-8EDB-E3C7CA47D42AQ24620915-F4CBC012-C7D4-496C-BC56-00B61167F337Q24632398-40AA1FAE-C8FD-470E-8784-3806A7590E3CQ26752873-D188632C-0752-4AA6-9DA3-448FBED18231Q26765357-9CCDA2AA-5C11-4561-8227-FCC601C220EEQ26767415-88A604C3-4FEF-4156-A859-D9F423A70A5EQ26769024-7A15C37B-2123-4554-BDC5-54AF2A21CB34Q26769649-77F1C93E-953F-4B8C-B55A-1171773B92ADQ26774293-742CA19B-349F-4A94-9934-E7F38EF69A99Q26783055-5C42CA93-4D9A-4BFD-B8A4-CFA024370388Q26822823-6E706140-030A-40EF-9D06-9F5FEDD32DCBQ26823498-44364959-B966-4B3D-90C1-34E579E01821Q26825186-89FF5B97-C3B2-48D1-A542-661CEFFFDEB0Q26828997-8B64E326-83E5-4FCE-8658-3F8774677EB7Q26849444-CEF4FEE2-72DC-490F-91DD-BC9B61AA618AQ26849671-8693BCDD-F8A4-44CF-82FC-73EF74C8530DQ26850125-AAAB58A9-FA44-4117-9ECC-C5ED72BC8299Q26853507-1C5D8C00-0C69-4EE4-81B8-14EF357FD224Q26864448-C0E837F4-2CF9-4708-A263-032998B9793AQ26864876-5E23F175-729B-4720-9B52-E64578D4F232Q26866803-8B6779B6-0721-4C4A-878C-EF35DA2B2AEEQ27002537-20511E1B-849F-4042-B56E-9E4F50E0DD18Q27006938-2B5C813D-1D81-440E-9A30-22C230910954Q27013013-42379D2B-B2A1-4CD9-965F-0F8FA345F904Q27014126-D3207CB6-22AE-4E86-9EBC-16E86665A010Q27020991-70AB3B53-34BD-4CBC-973C-911C5746F311Q27021788-580143AB-99B2-4B0A-B133-2C5E73536ABDQ27024092-D577F120-925C-4135-B778-73F3610A1842Q27026531-0D6FDD2D-C117-4B28-BF74-9D199B9B8589Q27027655-64F6415A-4AE7-451F-8347-6473F66501D5Q27321859-1D290B81-AF5B-492F-9A50-D8AC7A94830BQ27337984-A69B9A5F-11BE-4DE2-A605-3053FF378C1EQ27692697-B66D3A4B-16C4-430D-9ECD-654F7B06733AQ27852162-06589188-0CBC-45BE-BCA6-F073085A5B1EQ28069856-6A585656-FD23-4AD8-B2E2-611D6422A110Q28073967-4B945F54-411E-4CC2-B389-55ABCDE2B1B2
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The life history of 21 breast cancers
@ast
The life history of 21 breast cancers
@en
type
label
The life history of 21 breast cancers
@ast
The life history of 21 breast cancers
@en
prefLabel
The life history of 21 breast cancers
@ast
The life history of 21 breast cancers
@en
P2093
P2860
P50
P3181
P1433
P1476
The life history of 21 breast cancers
@en
P2093
Alexandrov LB
Aparicio SA
Bignell GR
Campbell PJ
P2860
P304
P3181
P356
10.1016/J.CELL.2012.04.023
P407
P50
P577
2012-05-25T00:00:00Z